Related Experiment Video
Updated: Jul 8, 2025

10:05
Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018
35.9K
Daratumumab for autoimmune diseases: a systematic review
Marie-Therese Holzer1, Nikolas Ruffer2, Tobias B Huber3
1Division of Rheumatology and Systemic Inflammatory Diseases, III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany m.holzer@uke.de.
RMD Open
|December 15, 2023
Summary
Daratumumab, a CD38-targeting antibody, shows promise for refractory autoimmune diseases, with 81% of patients experiencing remission or improvement. Further clinical trials are needed to optimize its use and manage side effects.
Area of Science:
- Immunology
- Rheumatology
- Pharmacology
Background:
- Refractory autoimmune diseases pose significant clinical challenges.
- Novel therapeutic strategies are essential for managing these conditions.
Conclusions:
- CD38-targeting with daratumumab presents a promising therapeutic avenue for refractory autoimmune diseases.
- Further research is required to determine optimal treatment regimens and manage adverse events.
- Systematic clinical trials are necessary to validate this therapeutic approach.
Related Concept Videos
Autoimmune Disorders
447
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
447
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529

